Open access
258
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS
Fernando J Martinez1 Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0002-2412-3182View further author information
Gary T Ferguson2 Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USAView further author information
, Eric Bourne3 AstraZeneca, Durham, NC, USA
https://orcid.org/0000-0003-3915-320XView further author information
Shaila Ballal4 AstraZeneca, Morristown, NJ, USAView further author information
, Patrick Darken5 AstraZeneca, Wilmington, DE, USA
https://orcid.org/0000-0002-5608-2717View further author information
Magnus Aurivillius6 AstraZeneca, Gothenburg, SwedenView further author information
, Paul Dorinsky3 AstraZeneca, Durham, NC, USA
https://orcid.org/0000-0002-4814-0657View further author information
Colin Reisner4 AstraZeneca, Morristown, NJ, USAView further author information
show all
Pages 179-189
|
Published online: 28 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.